Anavex Life Sciences (AVXL) Return on Equity [ROE] (2017 - 2026)
Anavex Life Sciences' Return on Equity [ROE] was -14.85% in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 40.00 percentage points from -54.85% a year earlier and up 16.22 percentage points from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Return on Equity [ROE] (2017 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Return on Equity [ROE] at Anavex Life Sciences came in at -47.79%, down 14.98 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of +62.80 percentage points (FY2020 to FY2025).
- In earlier fiscal years, Return on Equity [ROE] was -32.81% in FY2024 (+0.60 pp), -33.41% in FY2023 (-0.69 pp), -32.72% in FY2022 (+9.87 pp) and -42.58% in FY2021 (+68.01 pp).
- The fiscal Q3 2026 figure marks the highest quarterly Return on Equity [ROE] in data going back to fiscal Q4 2017.
- Compared with a year earlier, Return on Equity [ROE] has increased for three straight quarters, with an average year-over-year change of -2.05 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q4 2021 (a gain of 76.57 percentage points); the worst was fiscal Q3 2025 (a drop of 23.53 percentage points).
- Per Business Quant data, AVXL's Return on Equity [ROE] in the three fiscal quarters before Q3 2026 was -31.08% (Q2 2026), -40.29% (Q1 2026) and -55.33% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Anavex Life Sciences | 187.25 Mn | -292.83 Mn | - | -14.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.85% |
| Mar 31, 2026 | -31.08% |
| Dec 31, 2025 | -40.29% |
| Sep 30, 2025 | -55.33% |
| Jun 30, 2025 | -54.85% |
| Mar 31, 2025 | -47.59% |
| Dec 31, 2024 | -41.58% |
| Sep 30, 2024 | -34.40% |
| Jun 30, 2024 | -31.33% |
| Mar 31, 2024 | -29.89% |
| Dec 31, 2023 | -31.03% |
| Sep 30, 2023 | -32.92% |
| Jun 30, 2023 | -35.34% |
| Mar 31, 2023 | -37.61% |
| Dec 31, 2022 | -36.08% |
| Sep 30, 2022 | -32.70% |
| Jun 30, 2022 | -29.96% |
| Mar 31, 2022 | -28.93% |
| Dec 31, 2021 | -27.53% |
| Sep 30, 2021 | -24.58% |
API Access
Anavex Life Sciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();